Table 2.
Pharmacokinetic parameter | Value for drug |
|||
---|---|---|---|---|
Plasma |
Cysts |
|||
ABZSO | ABZSO2 | ABZSO | ABZSO2 | |
AUC0–t (μg·h/ml[g]b) | 4.40 ± 0.4 A | 0.70 ± 0.2 A | 1.50 ± 0.1 B | 0.30 ± 0.1 C |
Cmax (μg/ml[g]c) | 2.60 ± 0.5 A | 0.40 ± 0.1 B | 0.50 ± 0.1 B | 0.10 ± 0.0 C |
Tmax (h) | 0.50 ± 0.1 A | 0.50 ± 0.1 A | 1.00 ± 0.0 A | 1.00 ± 0.0 A |
Dp | 5 min–6 h | 5 min–4 h | 5 min–6 h | 5 min–4 h |
See footnote a of Table 1 for abbreviations. Different letters next to values indicate statistical differences in the pharmacokinetic parameter (P < 0.05). Values are means ± SD for drug parameters after oral administration of ABZ to mice (5 mg/kg).
Plasma AUC is expressed as μg·h/ml and cyst AUC as μg·h/g.
Plasma Cmax is expressed in μg/ml and cyst Cmax in μg/g.